Bank of New York Mellon Corp - INTEGRA LIFESCIENCES HLDGS C ownership

INTEGRA LIFESCIENCES HLDGS C's ticker is IART and the CUSIP is 457985208. A total of 258 filers reported holding INTEGRA LIFESCIENCES HLDGS C in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of INTEGRA LIFESCIENCES HLDGS C
ValueSharesWeighting
Q3 2023$25,232,079
-9.6%
660,699
-2.7%
0.01%0.0%
Q2 2023$27,926,529
-32.4%
678,982
-5.7%
0.01%
-33.3%
Q1 2023$41,331,561
+1.7%
719,937
-0.7%
0.01%0.0%
Q4 2022$40,642,657
+23.3%
724,856
-6.9%
0.01%
+12.5%
Q3 2022$32,967,000
-20.1%
778,234
+1.9%
0.01%
-11.1%
Q2 2022$41,271,000
-14.5%
763,839
+1.7%
0.01%0.0%
Q1 2022$48,267,000
-12.7%
751,132
-9.0%
0.01%
-10.0%
Q4 2021$55,278,000
+7.5%
825,191
+9.9%
0.01%0.0%
Q3 2021$51,432,000
+13.2%
751,030
+12.8%
0.01%
+11.1%
Q2 2021$45,427,000
-1.7%
665,714
-0.4%
0.01%0.0%
Q1 2021$46,195,000
+5.4%
668,621
-1.0%
0.01%
-10.0%
Q4 2020$43,844,000
+26.1%
675,351
-8.3%
0.01%
+11.1%
Q3 2020$34,783,000
-3.5%
736,598
-4.0%
0.01%
-10.0%
Q2 2020$36,062,000
+13.9%
767,444
+8.3%
0.01%0.0%
Q1 2020$31,664,000
-25.2%
708,848
-2.3%
0.01%
-9.1%
Q4 2019$42,305,000
-2.1%
725,883
+0.9%
0.01%
-8.3%
Q3 2019$43,224,000
+5.6%
719,550
-1.8%
0.01%
+9.1%
Q2 2019$40,922,000
+0.3%
732,715
+0.1%
0.01%0.0%
Q1 2019$40,790,000
+23.1%
732,055
-0.3%
0.01%
+10.0%
Q4 2018$33,128,000
-33.1%
734,537
-2.3%
0.01%
-23.1%
Q3 2018$49,514,000
+3.3%
751,700
+1.0%
0.01%0.0%
Q2 2018$47,931,000
+19.2%
744,153
+2.4%
0.01%
+18.2%
Q1 2018$40,217,000
+13.8%
726,722
-1.5%
0.01%
+22.2%
Q4 2017$35,328,000
-5.3%
738,154
-0.1%
0.01%
-10.0%
Q3 2017$37,312,000
-10.8%
739,169
-3.6%
0.01%
-16.7%
Q2 2017$41,813,000
+28.5%
767,089
-0.7%
0.01%
+33.3%
Q1 2017$32,536,000
-32.9%
772,248
+36.7%
0.01%
-35.7%
Q4 2016$48,472,000
+0.4%
565,014
-3.4%
0.01%0.0%
Q3 2016$48,263,000
+1.5%
584,644
-1.9%
0.01%
-6.7%
Q2 2016$47,531,000
+17.4%
595,761
-0.9%
0.02%
+25.0%
Q1 2016$40,482,000
+77.9%
600,978
+79.0%
0.01%
+71.4%
Q4 2015$22,758,000
+13.1%
335,765
-0.7%
0.01%
+16.7%
Q3 2015$20,130,000
+16.9%
338,031
+32.2%
0.01%
+20.0%
Q2 2015$17,226,000
+15.5%
255,693
+5.7%
0.01%
+25.0%
Q1 2015$14,909,000
+15.5%
241,851
+1.6%
0.00%
+33.3%
Q4 2014$12,907,000
+12.0%
238,002
+2.5%
0.00%0.0%
Q3 2014$11,521,000
-43.2%
232,092
-46.2%
0.00%0.0%
Q2 2014$20,288,000
+97.1%
431,116
+92.6%
0.00%0.0%
Q1 2014$10,295,000
+4.8%
223,871
+8.8%
0.00%0.0%
Q4 2013$9,819,000
-32.4%
205,791
-43.0%
0.00%
+50.0%
Q3 2013$14,530,000
+82.5%
360,998
+66.1%
0.00%
-33.3%
Q2 2013$7,961,000217,3620.00%
Other shareholders
INTEGRA LIFESCIENCES HLDGS C shareholders Q3 2021
NameSharesValueWeighting ↓
Tributary Capital Management, LLC 414,578$28,291,0002.14%
Champlain Investment Partners, LLC 6,510,030$444,244,0002.11%
COOKE & BIELER LP 2,750,361$187,685,0001.74%
Sapience Investments, LLC 161,660$11,032,0001.37%
Laurus Investment Counsel Inc. 35,933$3,043,0000.94%
Hood River Capital Management LLC 432,824$29,536,0000.88%
Mitsubishi UFJ Asset Management (UK) Ltd. 23,400$1,597,0000.69%
GW&K Investment Management, LLC 726,682$49,589,0000.43%
Olstein Capital Management, L.P. 46,000$3,139,0000.40%
Quantinno Capital Management LP 5,088$347,0000.39%
View complete list of INTEGRA LIFESCIENCES HLDGS C shareholders